Osaka, Japan

Takeshi Nagaura


 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Takeshi Nagaura

Introduction

Takeshi Nagaura is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target Trk-related diseases. With a total of 7 patents to his name, Nagaura's work is recognized for its potential impact on various medical conditions.

Latest Patents

Nagaura's latest patents include a Trk-inhibiting compound that serves as a drug for the prophylaxis and therapy of Trk-related diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease, and Chagas disease. This compound is characterized by a general formula (I), where all symbols represent specific meanings as described in the specification. Additionally, he has developed an acid-addition salt of the Trk-inhibiting compound, which selectively inhibits NGF vascular hyper permeability. This compound is notable for its excellent solubility and absorbability against free bases, making it a promising candidate for therapeutic applications.

Career Highlights

Takeshi Nagaura is currently associated with Ono Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work at Ono has allowed him to focus on innovative drug development, particularly in the area of Trk-related therapies. Nagaura's research has the potential to improve treatment options for patients suffering from various chronic conditions.

Collaborations

Nagaura has collaborated with notable colleagues such as Jun Takeuchi and Satoshi Itadani. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Takeshi Nagaura's innovative work in the pharmaceutical field highlights his commitment to addressing significant medical challenges. His contributions, particularly in the area of Trk-inhibiting compounds, demonstrate the potential for advancements in therapeutic options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…